Exicure Inc Stock price
Is Exicure Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Exicure Inc Stock Analysis
Analyst Opinions
6 Analysts have issued a Exicure Inc forecast:
Analyst Opinions
6 Analysts have issued a Exicure Inc forecast:
Don't miss a Thing! We will send you all news about Exicure Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Exicure Inc Stock News
Company Profile
Exicure, Inc. is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). It focuses on neurology, immuno-oncology, inflammatory diseases, and other genetic disorders. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.
| Head office | United States |
| CEO | Mr. Kim |
| Employees | 8 |
| Founded | 2011 |
| Website | www.exicuretx.com |


